Analyst Ratings for Denali Therapeutics Inc. (DNLI)
DNLI Rating Summary
DNLI Price Target Summary
- Highest: $105.00 (H.C. Wainwright)
- Lowest: $26.00 (Stifel)
- Average: $47.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$47.40 (+135.9%)
* Over Last 12-Mos
Rating Score: 8.6 / 10 Percentile Rank: 88%
Rating Score: 8.6 / 10 Percentile Rank: 88%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
12/13/2023 | Citi | David Hoang | New Coverage | Buy (N/A) |
32.00 (N/A) |
18.24 (20.09) |
10.14% | Details |
11/20/2023 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
28.00 (N/A) |
18.13 (20.09) |
10.81% | Details |